Virginia Pate, MS

Analyst
University of North Carolina at Chapel Hill

Poster(s):

(035) Assessing the utility of claims for haemoglobin A1c performance measures in characterizing glycemic control in older adult Medicare beneficiaries with diabetes.

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(051) Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: Impact of Study Design Differences on Treatment Effect

Wednesday, August 28, 2024
8:00 AM – 1:30 PM CEST
(100) Developing a novel claim-based algorithm to identify incident and prevalent dementia using Medicare claims of the Atherosclerosis Risk in Communities (ARIC) cohort

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(129) Older US adults refilling potentially inappropriate medications after hip fracture

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(143) The prevalent new-user study design: a novel application to estimating the average treatment effect of statin discontinuation on mortality among traditional Medicare beneficiaries who discontinued statins

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(174) Comparing publicly available methods for assessing covariate balance using standardized differences after implementation of weighting strategies

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(BSPOT05) Interpreting Effect Estimates Across Racial and Ethnic Categories in Propensity Score-Based Analyses: An Application in US Medicare Beneficiaries Initiating Antidiabetic Medications

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(BSPOT19) Estimating the Risk of Gestational Diabetes Mellitus Associated With Antidepressant Continuation During Pregnancy Using a Treatment Decision Study Design

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(CSPOT14) Multinational prescribing trends of lithium from 2001 to 2019: a retrospective observational study using population-based databases from 17 countries and one special administrative region

Wednesday, August 28, 2024
8:00 AM – 1:30 PM CEST